Results 81 to 90 of about 316,189 (194)
Microangiopathy in diabetic polyneuropathy revisited.
Microangiopathy is a major cause in diabetic polyneuropathy (DPN). This review examines evidence from both human and animal studies to elucidate the important microvascular factors in DPN.This is a literature review of articles published on PubMed in English.There is an abundance of evidence linking endoneurial microvascular abnormalities to peripheral
Fang, F. +3 more
openaire +2 more sources
The indicators of stimulation electroneuromyography in patients with diabetic polyneuropathy
The work is dedicated to researching of the effect of cocarnit on the functional state of the peripheral nerves based on the findings of stimulation electroneuromyography in multimodality treatment of diabetic polyneuropathy.
Pavlovych, L.B., Bilous, I.I.
core
Diabetic foot disease and oedema [PDF]
Diabetic foot ulcers (DFUs) are common and disabling, giving rise to significant morbidity and mortality as well as worldwide socioeconomic problems. Despite treatment, DFUs readily become chronic wounds and may lead to major lower limb amputations.
Leigh, RD, Tsui, J, Ho, TK
core
A three‐round Delphi consensus developed GCC‐specific, evidence‐based recommendations for diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy (PND). The consensus emphasizes proactive screening, early multimodal management, and addressing regional barriers to improve early detection, optimize management, and enhance quality of life ...
Abdulrahman Alshaikh +13 more
wiley +1 more source
Blink reflex alterations in diabetic patients with or without polyneuropathy
The main aim of this study is to evaluate the role of blink reflex for early diagnosis of cranial neuropathy in diabetic patients with or without polneuropathy.
Guney, Figen +2 more
core +1 more source
SGLT2i use and fracture risk compared with DPP4i in patients with T2DM
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin +5 more
wiley +1 more source
Cocarnit in the multimodality treatment of diabetic polyneuropathy
The work is dedicated to researching of the effect of cocarnit on the functional state of the peripheral nerves based on the findings of stimulation electroneuromyography in multimodality treatment of diabetic polyneuropathy.
Bilous, I.I. +2 more
core
The sensitivity of electromyoneurography in the diagnosis of diabetic polyneuropathy
Diabetic polyneuropathy is a complex set of clinical syndromes, which deplete various regions of the nervous system. The process leading to diabetic neuropathy is multi-factorial. Its symptoms are paresthesia, dysesthesia and pain.
Miroslav Ilin +4 more
core +1 more source
Combined nerve conduction index in diabetic polyneuropathy [PDF]
Diabetic polyneuropathy can be confirmed by nerve conduction studies. The data can be analyzed in the form of a combined index instead of individual parameters.
Flavia Costa Nunes Machado +3 more
core +1 more source
The authors have studied the effect of mildronat and thiotriazolin on the processes of lipid peroxidation, the oxidative modification of proteins and the state of the blood antioxidant system 3 and 6 months following a course of multimodality treatment ...
Bilous, I.I. +3 more
core

